LT4551B - 4-[5-metil-3-fenilizoksazol-4-il]benzensulfonamido kristalinė forma - Google Patents
4-[5-metil-3-fenilizoksazol-4-il]benzensulfonamido kristalinė forma Download PDFInfo
- Publication number
- LT4551B LT4551B LT99-024A LT99024A LT4551B LT 4551 B LT4551 B LT 4551B LT 99024 A LT99024 A LT 99024A LT 4551 B LT4551 B LT 4551B
- Authority
- LT
- Lithuania
- Prior art keywords
- methyl
- benzenesulfonamide
- treatment
- phenylisoxazol
- methanol
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
- H01L23/40—Mountings or securing means for detachable cooling or heating arrangements ; fixed by friction, plugs or springs
- H01L23/4006—Mountings or securing means for detachable cooling or heating arrangements ; fixed by friction, plugs or springs with bolts or screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
- H01L23/42—Fillings or auxiliary members in containers or encapsulations selected or arranged to facilitate heating or cooling
- H01L23/427—Cooling by change of state, e.g. use of heat pipes
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/0001—Technical content checked by a classifier
- H01L2924/0002—Not covered by any one of groups H01L24/00, H01L24/00 and H01L2224/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Power Engineering (AREA)
- Computer Hardware Design (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
Piko Nr. | Kampas -2Θ (lps) | D išbarstymas | Pikas Cps | I/I max (%) |
a | b | c | d | e |
1 | 12,221 | 7,2361 | 502,38 | 63,29 |
2 | 13,693 | 6,4617 | 38,03 | 4,79 |
3 | 14,227 | 6,2203 | 51,46 | 6,48 |
4 | 15,447 | 5,7314 | 599,94 | 75,58 |
r | 15,801 | 5,6039 | 793,79 | 100,00 |
6 | 16,678 | 5,3110 | 239,95 | 30,23 |
7 | 17,081 | 5,1868 | 331,31 | 41,74 |
8 | 18,165 | 4,8796 | 270,21 | 34,04 |
9 | 19,066 | 4,6510 | 73,16 | 9,22 |
10 | 19,400 | 4,5717 | 200,13 | 25,21 |
11 | 19,798 | 4,4807 | 789,23 | 99,43 |
12 | 20,578 | 4,3126 | 209,43 | 26,38 |
13 | 22,008 | 4,0354 | 691,33 | 87,09 |
14 | 22,540 | 3,9414 | 71,87 | 9,05 |
15 | 22,975 | 3,8678 | 137,23 | 17,29 |
16 | 23,580 | 3,7699 | 394,27 | 49,67 |
17 | 23,861 | 3,7261 | 602,27 | 75,87 |
18 | 24,553 | 3,6226 | 397,23 | 50,04 |
19 | 25,206 | 3,5302 | 192,44 | 24,24 |
20 | 25,560 | 3,4822 | 77,74 | 9,79 |
21 | 25,940 | 3,4320 | 31,47 | 3,96 |
22 | 26,200 | 3,3985 | 20,87 | 2,63 |
23 | 27,295 | 3,2646 | 151,54 | 19,09 |
24 | 28,595 | 3,1191 | 207,74 | 26,17 |
25 | 29,124 | 3,0636 | 161,44 | 20,34 |
26 | 29,656 | 3,0099 | 73,94 | 9,32 |
«r-v»'· *-·.» 'V' £> J- N-/N-A UK | CGS-25019C, | Leo | Denmark produkto | ETH-615, Lilly |
produkto | LY-293111, | ONO | produkto ONO-4057 ir Terumo | |
produkto | TMK-688. | |||
Be kitų | , tinkami | 5 - LO | inhibitoriai | apima, Abbott |
Claims (10)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2437896P | 1996-08-14 | 1996-08-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
LT99024A LT99024A (lt) | 1999-07-26 |
LT4551B true LT4551B (lt) | 1999-10-25 |
Family
ID=21820280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LT99-024A LT4551B (lt) | 1996-08-14 | 1999-03-10 | 4-[5-metil-3-fenilizoksazol-4-il]benzensulfonamido kristalinė forma |
Country Status (39)
Country | Link |
---|---|
US (2) | US6441014B2 (lt) |
EP (2) | EP1283203A1 (lt) |
JP (2) | JP3631763B2 (lt) |
KR (1) | KR100383148B1 (lt) |
CN (1) | CN1205193C (lt) |
AP (1) | AP1055A (lt) |
AR (1) | AR009244A1 (lt) |
AT (1) | ATE228117T1 (lt) |
AU (1) | AU722072B2 (lt) |
BG (1) | BG64259B1 (lt) |
BR (1) | BR9711151A (lt) |
CA (1) | CA2264104A1 (lt) |
CZ (1) | CZ297679B6 (lt) |
DE (1) | DE69717281T2 (lt) |
DK (1) | DK0920422T3 (lt) |
EA (2) | EA003754B1 (lt) |
EE (1) | EE04237B1 (lt) |
ES (1) | ES2188971T3 (lt) |
GE (1) | GEP20022636B (lt) |
HK (1) | HK1023125A1 (lt) |
HU (1) | HUP0400923A3 (lt) |
IL (2) | IL128255A (lt) |
IS (1) | IS1989B (lt) |
LT (1) | LT4551B (lt) |
LV (1) | LV12274B (lt) |
NO (1) | NO312461B1 (lt) |
NZ (1) | NZ334132A (lt) |
OA (1) | OA11298A (lt) |
PL (1) | PL191313B1 (lt) |
PT (1) | PT920422E (lt) |
RO (1) | RO120771B1 (lt) |
RS (1) | RS49671B (lt) |
SI (1) | SI9720059B (lt) |
SK (1) | SK283558B6 (lt) |
TR (1) | TR199900298T2 (lt) |
TW (1) | TW527350B (lt) |
UA (1) | UA52684C2 (lt) |
WO (1) | WO1998006708A1 (lt) |
ZA (1) | ZA977314B (lt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2188971T3 (es) * | 1996-08-14 | 2003-07-01 | Searle & Co | Forma cristalina de la 4-(5-metil-3-fenilisoxazol-4-il)benzensulfonamida. |
US6887893B1 (en) * | 1997-12-24 | 2005-05-03 | Sankyo Company, Limited | Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia |
GB9810920D0 (en) * | 1998-05-21 | 1998-07-22 | Merck Sharp & Dohme | Therapeutic use |
WO2000008001A1 (en) * | 1998-08-07 | 2000-02-17 | Chiron Corporation | Substituted isoxazole as estrogen receptor modulators |
AU1398899A (en) * | 1998-11-12 | 2000-06-05 | Algos Pharmaceutical Corporation | Cox-2 inhibitors in combination with centrally acting analgesics |
MXPA01008903A (es) * | 1999-03-01 | 2003-07-21 | Johnson & Jonhson | Composicion que comprende un material de tramadol y un farmaco inhibidor de cox-2 selectivo. |
MXPA02001820A (es) | 1999-08-20 | 2003-07-14 | Johnson & Johnson | Composicion que comprende un material de tramadol y un farmaco anticonvulsivo. |
WO2001015687A1 (en) * | 1999-08-27 | 2001-03-08 | Merck & Co., Inc. | Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
EP1419151B1 (en) | 2001-08-15 | 2014-02-26 | Pharmacia & Upjohn Company LLC | Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl] -5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl] -2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
US20070072921A1 (en) * | 2002-07-26 | 2007-03-29 | Talley John J | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfonamide |
US7538126B2 (en) | 2003-04-04 | 2009-05-26 | Hetero Drugs Limited | Crystalline forms of valdecoxib |
ATE342722T1 (de) | 2003-05-07 | 2006-11-15 | Osteologix As | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
US20050182113A1 (en) * | 2003-12-30 | 2005-08-18 | Venkataraman Sundaram | Method for preparing diaryl-substituted isoxazole compounds |
US20050272787A1 (en) * | 2004-05-19 | 2005-12-08 | Eswaraiah Sajja | Process for preparing crystalline form A of valdecoxib |
WO2005120499A1 (en) * | 2004-06-10 | 2005-12-22 | Chandiran Thakashinamoorthy | Form a of valdecoxib suitable for pharmaceutical formulations |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
PT1612203E (pt) * | 2004-06-28 | 2007-08-20 | Gruenenthal Gmbh | ''formas cristalinas de cloridrato de (-) - (1r,2r) - 3 -(3-dimetilamino-l-etil - 2 - metilpropil) fenol'' |
KR100591786B1 (ko) | 2004-10-19 | 2006-06-26 | 휴먼팜 주식회사 | 프란루카스트를 함유하는 약학적 조성물 및 이의 제조 방법 |
JP2008545650A (ja) | 2005-05-20 | 2008-12-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | スルファミド誘導体の製造方法 |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
TW200812573A (en) | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
MX2011000090A (es) | 2008-06-23 | 2011-03-02 | Janssen Pharmaceutica Nv | Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]diox in-2-ilmetil)sulfamida. |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
CN103172583A (zh) * | 2013-03-07 | 2013-06-26 | 深圳市资福药业有限公司 | 一种制备帕瑞昔布的方法 |
US10028904B2 (en) | 2014-12-04 | 2018-07-24 | Wisconsin Alumni Research Foundation | Transdermal cannabinoid formulations |
US9375417B2 (en) | 2014-12-04 | 2016-06-28 | Mary's Medicinals LLC | Transdermal cannabinoid formulations |
CN114441666B (zh) * | 2020-11-05 | 2024-02-27 | 成都百裕制药股份有限公司 | 一种4-(5-甲基-3-苯基-4-异恶唑)苯磺酰氯中杂质的检测方法 |
WO2022195579A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996025405A1 (en) | 1995-02-13 | 1996-08-22 | G.D. Searle & Co. | Substituted isoxazoles for the treatment of inflammation |
US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
ES2188971T3 (es) * | 1996-08-14 | 2003-07-01 | Searle & Co | Forma cristalina de la 4-(5-metil-3-fenilisoxazol-4-il)benzensulfonamida. |
US7538126B2 (en) * | 2003-04-04 | 2009-05-26 | Hetero Drugs Limited | Crystalline forms of valdecoxib |
US20050272787A1 (en) * | 2004-05-19 | 2005-12-08 | Eswaraiah Sajja | Process for preparing crystalline form A of valdecoxib |
-
1997
- 1997-08-12 ES ES97938656T patent/ES2188971T3/es not_active Expired - Lifetime
- 1997-08-12 NZ NZ334132A patent/NZ334132A/en unknown
- 1997-08-12 KR KR10-1999-7001263A patent/KR100383148B1/ko not_active IP Right Cessation
- 1997-08-12 GE GEAP19974712A patent/GEP20022636B/en unknown
- 1997-08-12 AT AT97938656T patent/ATE228117T1/de not_active IP Right Cessation
- 1997-08-12 AP APAP/P/1999/001458A patent/AP1055A/en active
- 1997-08-12 EA EA200000891A patent/EA003754B1/ru not_active IP Right Cessation
- 1997-08-12 PT PT97938656T patent/PT920422E/pt unknown
- 1997-08-12 EP EP02025507A patent/EP1283203A1/en not_active Withdrawn
- 1997-08-12 JP JP51012198A patent/JP3631763B2/ja not_active Expired - Fee Related
- 1997-08-12 PL PL331607A patent/PL191313B1/pl not_active IP Right Cessation
- 1997-08-12 WO PCT/US1997/015126 patent/WO1998006708A1/en active IP Right Grant
- 1997-08-12 CZ CZ0033499A patent/CZ297679B6/cs not_active IP Right Cessation
- 1997-08-12 RO RO99-00176A patent/RO120771B1/ro unknown
- 1997-08-12 AU AU40936/97A patent/AU722072B2/en not_active Ceased
- 1997-08-12 EP EP97938656A patent/EP0920422B1/en not_active Expired - Lifetime
- 1997-08-12 DE DE69717281T patent/DE69717281T2/de not_active Expired - Fee Related
- 1997-08-12 IL IL12825597A patent/IL128255A/en not_active IP Right Cessation
- 1997-08-12 CA CA002264104A patent/CA2264104A1/en not_active Abandoned
- 1997-08-12 BR BR9711151A patent/BR9711151A/pt not_active Application Discontinuation
- 1997-08-12 CN CNB971985367A patent/CN1205193C/zh not_active Expired - Fee Related
- 1997-08-12 SI SI9720059A patent/SI9720059B/sl not_active IP Right Cessation
- 1997-08-12 HU HU0400923A patent/HUP0400923A3/hu unknown
- 1997-08-12 EE EEP199900053A patent/EE04237B1/xx not_active IP Right Cessation
- 1997-08-12 EA EA199900200A patent/EA001472B1/ru not_active IP Right Cessation
- 1997-08-12 DK DK97938656T patent/DK0920422T3/da active
- 1997-08-12 SK SK136-99A patent/SK283558B6/sk not_active IP Right Cessation
- 1997-08-12 IL IL16122497A patent/IL161224A0/xx unknown
- 1997-08-12 TR TR1999/00298T patent/TR199900298T2/xx unknown
- 1997-08-14 AR ARP970103706A patent/AR009244A1/es not_active Application Discontinuation
- 1997-08-14 ZA ZA977314A patent/ZA977314B/xx unknown
- 1997-10-14 TW TW086111783A patent/TW527350B/zh not_active IP Right Cessation
- 1997-12-08 UA UA99031377A patent/UA52684C2/uk unknown
-
1999
- 1999-01-29 IS IS4961A patent/IS1989B/is unknown
- 1999-02-05 NO NO19990541A patent/NO312461B1/no unknown
- 1999-02-08 BG BG103155A patent/BG64259B1/bg unknown
- 1999-02-12 RS YUP-74/99A patent/RS49671B/sr unknown
- 1999-02-12 OA OA9900031A patent/OA11298A/en unknown
- 1999-03-05 LV LVP-99-40A patent/LV12274B/en unknown
- 1999-03-10 LT LT99-024A patent/LT4551B/lt active Protection Beyond IP Right Term
-
2000
- 2000-04-19 HK HK00102376A patent/HK1023125A1/xx not_active IP Right Cessation
- 2000-12-19 US US09/741,213 patent/US6441014B2/en not_active Expired - Fee Related
-
2002
- 2002-07-26 US US10/205,732 patent/US7135489B2/en not_active Expired - Fee Related
-
2004
- 2004-10-15 JP JP2004301644A patent/JP2005015497A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996025405A1 (en) | 1995-02-13 | 1996-08-22 | G.D. Searle & Co. | Substituted isoxazoles for the treatment of inflammation |
US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT4551B (lt) | 4-[5-metil-3-fenilizoksazol-4-il]benzensulfonamido kristalinė forma | |
EP0946507B1 (en) | Substituted pyrrolyl compounds for the treatment of inflammation | |
US5859257A (en) | Isoxazole compounds as cyclooxygenase inhibitors | |
EP1379513B1 (en) | Prodrugs of cox-2 inhibitors | |
JP4049307B2 (ja) | Cox−2阻害剤のプロドラッグとしての置換ベンゼンスルホンアミド誘導体 | |
US20070072921A1 (en) | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfonamide | |
MXPA99001526A (en) | Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide | |
EP1369415A1 (en) | Substituted pyrrolyl compounds for the treatment of inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD9A | Change of patent owner |
Owner name: G.D. SEARLE & CO., US Effective date: 20041001 |
|
SPCF | Filing an spc |
Free format text: PRODUCT NAME: VALDECOXIBUM ( 4-(5-METIL-3-FENIL-4-IZOKSAZOLIL)BENZENSULFONAMIDAS); REGISTRATION NO/DATE: 03/8255/7, 2003 09 09; 03/8256/7, 2003 09 09; 03/8257/7 20030909 Spc suppl protection certif: PA2004006 Filing date: 20041001 Expiry date: 20170812 |
|
ND9D | Filing a supplementary protection certificate |
Free format text: PRODUCT NAME: VALDECOXIBUM - 4-[5-METIL-3-FENIL-4-IZOKSAZOLIL]BENZENSULFONAMIDAS Spc suppl protection certif: PA2004006 Filing date: 20041001 |
|
SPCG | Grant of an spc |
Free format text: PRODUCT NAME: VALDECOXIBUM ( 4-(5-METIL-3-FENIL-4-IZOKSAZOLIL)BENZENSULFONAMIDAS); REGISTRATION NO/DATE: 03/8255/7, 2003 09 09; 03/8256/7, 2003 09 09; 03/8257/7 20030909 Spc suppl protection certif: PA2004006,C4551 Filing date: 20041001 Expiry date: 20170812 Extension date: 20180908 |
|
MM9A | Lapsed patents |
Effective date: 20090812 |
|
SPCW | Withdrawal of an spc |
Free format text: PRODUCT NAME: VALDECOXIBUM ( 4-(5-METIL-3-FENIL-4-IZOKSAZOLIL)BENZENSULFONAMIDAS); REGISTRATION NO/DATE: 03/8255/7, 2003 09 09; 03/8256/7, 2003 09 09; 03/8257/7 20030909 Spc suppl protection certif: PA2004006,C4551 Filing date: 20041001 Expiry date: 20170812 Extension date: 20180908 Effective date: 20090812 |